Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017, Article ID 7218562, 14 pages
https://doi.org/10.1155/2017/7218562
Research Article

Potential Antitumor Activity and Apoptosis Induction of Glossostemon bruguieri Root Extract against Hepatocellular Carcinoma Cells

1Botany and Microbiology Department, Science College, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia
2Molecular Biology Unit, Zoology Department, Faculty of Science, Alexandria University, P.O. Box 21511, Alexandria, Egypt
3Botany and Microbiology Department, Faculty of Science, Alexandria University, P.O. Box 21511, Alexandria, Egypt
4Biochemistry Department, Faculty of Science, Alexandria University, P.O. Box 21511, Alexandria, Egypt
5Oncology Department, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20057, USA

Correspondence should be addressed to Ahmed S. Sultan; ge.ude.uxela@natlusa_rd

Received 19 June 2016; Revised 12 September 2016; Accepted 12 January 2017; Published 22 March 2017

Academic Editor: Cheorl-Ho Kim

Copyright © 2017 Mona S. Alwhibi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Ebere Okwu and F. Uchenna Nnamdi, “A novel antimicrobial phenanthrene alkaloid from Bryopyllum pinnatum,” Journal of Chemistry, vol. 8, no. 3, pp. 1456–1461, 2011. View at Google Scholar
  2. A. A. Sowemimo, F. A. Fakoya, I. Awopetu, O. R. Omobuwajo, and S. A. Adesanya, “Toxicity and mutagenic activity of some selected Nigerian plants,” Journal of Ethnopharmacology, vol. 113, no. 3, pp. 427–432, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. J. W. Purseglove, Tropical Crops. Dicotyledons Volumes 1 and 2, Longmans, 1968.
  4. Y. Shabatai and I. Osman, Cultivation of Moghat Plant in Egypt, Ministry of Agriculture, Cairo, Egypt, 1939.
  5. I. Sina and A. Ali, Al Qanoon fil Tibb, English Translation of the Critical Arabic Text, Book-I, 1993.
  6. M. R. Meselhy, “Constituents from Moghat, the roots of Glossostemon bruguieri (Desf.),” Molecules, vol. 8, no. 8, pp. 614–621, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Ibrahim, W. El-Eraky, S. El-Gengaihi, and A. S. Shalaby, “Chemical and biological evaluation of proteins and mucilages from roots and seeds of Glossostemon bruguieri Desf. (Moghat),” Plant Foods for Human Nutrition, vol. 50, no. 1, pp. 55–61, 1997. View at Publisher · View at Google Scholar · View at Scopus
  8. E. S. Amin, O. Awad, M. A. El Samad, and M. N. Iskander, “Isolation of estrone from moghat roots and from pollen grains of egyptian date palm,” Phytochemistry, vol. 8, no. 1, pp. 295–297, 1969. View at Publisher · View at Google Scholar · View at Scopus
  9. N. H. El-Sayed, A. S. Awaad, and T. J. Mabry, “Phytochemical studies and effect on urine volume of Glossostemon bruguieri Desf. constituents,” Indian Journal of Experimental Biology, vol. 42, no. 2, pp. 186–189, 2004. View at Google Scholar · View at Scopus
  10. M. Sharaf, M. A. El-Ansari, and N. A. M. Saleh, “A new flavonoid from the roots of Glossostemon bruguieri,” Fitoterapia, vol. 69, no. 1, pp. 47–48, 1998. View at Google Scholar · View at Scopus
  11. T. H. Gamel, A. M. A. El-Razek, and A. A. Damir, “Dried peeled roots of glossostemon bruguieri (moghat) as a potential functional food,” Journal of Food Processing and Preservation, vol. 34, no. 1, pp. 55–67, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. D. A. Ghareeb, F. H. El-Rashidy, and S. El-Mallawany, “Imbalanced diet deficient in calcium and vitamin D-induced juvenile osteopenia in rats; the potential therapeutic effect of Egyptian Moghat roots water extract (Glossostemon bruguieri),” Iranian Journal of Pharmaceutical Research, vol. 13, no. 2, pp. 623–635, 2014. View at Google Scholar · View at Scopus
  13. Y. Takada and B. B. Aggarwal, “Betulinic acid suppresses carcinogen-induced NF-κB activation through inhibition of IκBα kinase and p65 phosphorylation: abrogation of cyclooxygenase-2 and matrix metalloprotease-9,” Journal of Immunology, vol. 171, no. 6, pp. 3278–3286, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Ferlay, I. Soerjomataram, R. Dikshit et al., “Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012,” International Journal of Cancer, vol. 136, no. 5, pp. E359–E386, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. K. K. Lee, D. G. Kim, I. S. Moon, M. D. Lee, and J. H. Park, “Liver transplantation versus liver resection for the treatment of hepatocellular carcinoma,” Journal of Surgical Oncology, vol. 101, no. 1, pp. 47–53, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Alsemari, F. Alkhodairy, A. Aldakan et al., “The selective cytotoxic anti-cancer properties and proteomic analysis of Trigonella Foenum-Graecum,” BMC Complementary and Alternative Medicine, vol. 14, no. 1, article 114, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. X. Liu, V. Ory, S. Chapman et al., “ROCK inhibitor and feeder cells induce the conditional reprogramming of epithelial cells,” The American Journal of Pathology, vol. 180, no. 2, pp. 599–607, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Chapman, X. Liu, C. Meyers, R. Schlegel, and A. A. McBride, “Human keratinocytes are efficiently immortalized by a Rho kinase inhibitor,” Journal of Clinical Investigation, vol. 120, no. 7, pp. 2619–2626, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. Z. Wang, C. Dabrosin, X. Yin et al., “Broad targeting of angiogenesis for cancer prevention and therapy,” Seminars in Cancer Biology, vol. 35, pp. S224–S243, 2015. View at Google Scholar
  20. M. I. M. Khalil, M. M. Ibrahim, G. A. El-Gaaly, and A. S. Sultan, “Trigonella foenum (Fenugreek) induced apoptosis in hepatocellular carcinoma cell line, HepG2, mediated by upregulation of p53 and proliferating cell nuclear antigen,” BioMed Research International, vol. 2015, Article ID 914645, 11 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. R. K. Lall, D. N. Syed, V. M. Adhami, M. I. Khan, and H. Mukhtar, “Dietary polyphenols in prevention and treatment of prostate cancer,” International Journal of Molecular Sciences, vol. 16, no. 2, pp. 3350–3376, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. S.-F. Zhang, X.-L. Wang, X.-Q. Yang, and N. Chen, “Autophagy-associated targeting pathways of natural products during cancer treatment,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 24, pp. 10557–10563, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. B. B. Aggarwal and S. Shishodia, “Molecular targets of dietary agents for prevention and therapy of cancer,” Biochemical Pharmacology, vol. 71, no. 10, pp. 1397–1421, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. B. Aboul-Enein, “Cultural implications of moghat (Glossostemon bruguieri) and breastfeeding in Egypt: a brief narrative review,” Online Journal of Cultural Competence in Nursing and Healthcare, vol. 3, no. 4, pp. 15–19, 2013. View at Publisher · View at Google Scholar
  25. E. S. Amin and O. M. Awad, “The mucilage of the roots of clossostemon bruguieri (moghat),” Carbohydrate Research, vol. 7, no. 1, pp. 12–16, 1968. View at Publisher · View at Google Scholar · View at Scopus
  26. M. D. Jacobson, M. Weil, and M. C. Raff, “Programmed cell death in animal development,” Cell, vol. 88, no. 3, pp. 347–354, 1997. View at Publisher · View at Google Scholar · View at Scopus
  27. X. Liu, H. Zou, C. Slaughter, and X. Wang, “DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis,” Cell, vol. 89, no. 2, pp. 175–184, 1997. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Corbiere, B. Liagre, F. Terro, and J.-L. Beneytout, “Induction of antiproliferative effect by diosgenin through activation of p53, release of apoptosis-inducing factor (AIF) and modulation of caspase-3 activity in different human cancer cells,” Cell Research, vol. 14, no. 3, pp. 188–196, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. M. I. Alhazmi, T. N. Hasan, G. Shafi, A. H. Al-Assaf, M. A. Alfawaz, and A. A. Alshatwi, “Roles of p53 and caspases in induction of apoptosis in MCF-7 breast cancer cells treated with a methanolic extract of nigella sativa seeds,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 22, pp. 9655–9660, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. E. S. Al-Sheddi, N. N. Farshori, M. M. Al-Oqail, J. Musarrat, A. A. Al-Khedhairy, and M. A. Siddiqui, “Cytotoxicity of Nigella Sativa seed oil and extract against human lung cancer cell line,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 2, pp. 983–987, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Das, K. K. Dey, G. Dey et al., “Antineoplastic and apoptotic potential of traditional medicines thymoquinone and diosgenin in squamous cell carcinoma,” PLoS ONE, vol. 7, no. 10, Article ID e46641, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. M. A. El-Mahdy, Q. Zhu, Q.-E. Wang, G. Wani, and A. A. Wani, “Thymoquinone induces apoptosis through activation of caspase-8 and mitochondrial events in p53-null myeloblastic leukemia HL-60 cells,” International Journal of Cancer, vol. 117, no. 3, pp. 409–417, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. W. S. El-Deiry, T. Tokino, V. E. Velculescu et al., “WAF1, a potential mediator of p53 tumor suppression,” Cell, vol. 75, no. 4, pp. 817–825, 1993. View at Publisher · View at Google Scholar · View at Scopus
  34. P.-L. Kuo and C.-C. Lin, “Green tea constituent (-)-epigallocatechin-3-gallate inhibits Hep G2 cell proliferation and induces apoptosis through p53-dependent and fas-mediated pathways,” Journal of Biomedical Science, vol. 10, no. 2, pp. 219–227, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Gupta, N. Ahmad, A.-L. Nieminen, and H. Mukhtar, “Growth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent (-)-epigallocatechin-3-gallate in androgen-sensitive and androgen-insensitive human prostate carcinoma cells,” Toxicology and Applied Pharmacology, vol. 164, no. 1, pp. 82–90, 2000. View at Publisher · View at Google Scholar · View at Scopus
  36. T. Choudhuri, S. Pal, M. L. Agwarwal, T. Das, and G. Sa, “Curcumin induces apoptosis in human breast cancer cells through p53-dependent Bax induction,” FEBS Letters, vol. 512, no. 1–3, pp. 334–340, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Liontas and H. Yeger, “Curcumin and resveratrol induce apoptosis and nuclear translocation and activation of p53 in human neuroblastoma,” Anticancer Research, vol. 24, no. 2B, pp. 987–998, 2004. View at Google Scholar · View at Scopus
  38. A. Shih, F. B. Davis, H.-Y. Lin, and P. J. Davis, “Resveratrol induces apoptosis in thyroid cancer cell lines via a MAPK- and p53-dependent mechanism,” The Journal of Clinical Endocrinology & Metabolism, vol. 87, no. 3, pp. 1223–1232, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. J. Raju, J. M. R. Patlolla, M. V. Swamy, and C. V. Rao, “Diosgenin, a steroid saponin of Trigonella foenum graecum (Fenugreek), inhibits azoxymethane-induced aberrant crypt foci formation in F344 rats and induces apoptosis in HT-29 human colon cancer cells,” Cancer Epidemiology Biomarkers and Prevention, vol. 13, no. 8, pp. 1392–1398, 2004. View at Google Scholar · View at Scopus
  40. R. Y. Mohammad, G. Somayyeh, H. Gholamreza, M. Majid, and R. Yousef, “Diosgenin inhibits hTERT gene expression in the A549 lung cancer cell line,” Asian Pacific Journal of Cancer Prevention, vol. 14, no. 11, pp. 6945–6948, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. S.-S. Han, S.-T. Chung, D. A. Robertson, D. Ranjan, and S. Bondada, “Curcumin causes the growth arrest and apoptosis of B cell lymphoma by downregulation of egr-1, C-myc, Bcl-XL, NF-κB, and p53,” Clinical Immunology, vol. 93, no. 2, pp. 152–161, 1999. View at Publisher · View at Google Scholar · View at Scopus
  42. K. Boehme, Y. Dietz, P. Hewitt, and S. O. Mueller, “Activation of P53 in HepG2 cells as surrogate to detect mutagens and promutagens in vitro,” Toxicology Letters, vol. 198, no. 2, pp. 272–281, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Takawa, H.-S. Cho, S. Hayami et al., “Histone lysine methyltransferase SETD8 promotes carcinogenesis by deregulating PCNA expression,” Cancer Research, vol. 72, no. 13, pp. 3217–3227, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. R. Bravo and H. Macdonald-Bravo, “Existence of two populations of cyclin/proliferating cell nuclear antigen during the cell cycle: association with DNA replication sites,” The Journal of Cell Biology, vol. 105, no. 4, pp. 1549–1554, 1987. View at Publisher · View at Google Scholar · View at Scopus
  45. Y. Fujiwara, T. Komiya, H. Kawabata et al., “Isolation of a DEAD-family protein gene that encodes a murine homolog of Drosophila vasa and its specific expression in germ cell lineage,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 25, pp. 12258–12262, 1994. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Scott, P. Bonnefin, D. Vieyra et al., “UV-induced binding of ING1 to PCNA regulates the induction of apoptosis,” Journal of Cell Science, vol. 114, no. 19, pp. 3455–3462, 2001. View at Google Scholar · View at Scopus
  47. M. Vairapandi, N. Azam, A. G. Balliet, B. Hoffman, and D. A. Liebermann, “Characterization of MyD118, Gadd45, and proliferating cell nuclear antigen (PCNA) interacting domains. PCNA impedes MyD118 and Gadd45-mediated negative growth control,” Journal of Biological Chemistry, vol. 275, no. 22, pp. 16810–16819, 2000. View at Publisher · View at Google Scholar · View at Scopus
  48. K. Fujise, D. Zhang, J.-L. Liu, and E. T. H. Yeh, “Regulation of apoptosis and cell cycle progression by MCL1. Differential role of proliferating cell nuclear antigen,” The Journal of Biological Chemistry, vol. 275, no. 50, pp. 39458–39465, 2000. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Hidaka, Y. Takagi, T. Y. Takano, and M. Sekiguchi, “PCNA-MutSα-mediated binding of MutLα to replicative DNA with mismatched bases to induce apoptosis in human cells,” Nucleic Acids Research, vol. 33, no. 17, pp. 5703–5712, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. S. A. Maxwell, S. A. Acosta, K. Tombusch, and G. E. Davis, “Expression of Bax, Bcl-2, Waf-1, and PCNA gene products in an immortalized human endothelial cell line undergoing p53-mediated apoptosis,” Apoptosis, vol. 2, no. 5, pp. 442–454, 1997. View at Publisher · View at Google Scholar · View at Scopus
  51. B. Xu, J. Hua, Y. Zhang et al., “Proliferating cell nuclear antigen (PCNA) regulates primordial follicle assembly by promoting apoptosis of oocytes in fetal and neonatal mouse ovaries,” PLoS ONE, vol. 6, no. 1, Article ID e16046, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. H.-W. Chang, Y.-C. Lai, C.-Y. Cheng, J.-L. Ho, S.-T. Ding, and Y.-C. Liu, “UV inducibility of rat proliferating cell nuclear antigen gene promoter,” Journal of Cellular Biochemistry, vol. 73, no. 3, pp. 423–432, 1999. View at Publisher · View at Google Scholar · View at Scopus
  53. P. Yu, B. Huang, M. Shen et al., “p15PAF, a novel PCNA associated factor with increased expression in tumor tissues,” Oncogene, vol. 20, no. 4, pp. 484–489, 2001. View at Publisher · View at Google Scholar · View at Scopus
  54. J. M. Gulbis, Z. Kelman, J. Hurwitz, M. O'Donnell, and J. Kuriyan, “Structure of the C-terminal region of p21WAF1/CIP1 complexed with human PCNA,” Cell, vol. 87, no. 2, pp. 297–306, 1996. View at Publisher · View at Google Scholar · View at Scopus
  55. S. Waga, G. J. Hannon, D. Beach, and B. Stillman, “The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA,” Nature, vol. 369, no. 6481, pp. 574–578, 1994. View at Publisher · View at Google Scholar · View at Scopus
  56. M. Savio, L. A. Stivala, A. I. Scovassi, L. Bianchi, and E. Prosperi, “P21(waf1/cip1) protein associates with the detergent-insoluble form of PCNA concomitantly with disassembly of PCNA at nucleotide excision repair sites,” Oncogene, vol. 13, no. 8, pp. 1591–1598, 1996. View at Google Scholar · View at Scopus
  57. R. A. Bambara, R. S. Murante, and L. A. Henricksen, “Enzymes and reactions at the eukaryotic DNA replication fork,” Journal of Biological Chemistry, vol. 272, no. 8, pp. 4647–4650, 1997. View at Publisher · View at Google Scholar · View at Scopus
  58. M. L. Agarwal, W. R. Taylor, M. V. Chernov, O. B. Chernova, and G. R. Stark, “The p53 network,” The Journal of Biological Chemistry, vol. 273, no. 1, pp. 1–4, 1998. View at Publisher · View at Google Scholar · View at Scopus
  59. H. J. Jung, H. L. Kim, Y. J. Kim, J.-I. Weon, and Y. R. Seo, “A novel chemopreventive mechanism of selenomethionine: enhancement of APE1 enzyme activity via a Gadd45a, PCNA and APE1 protein complex that regulates p53-mediated base excision repair,” Oncology Reports, vol. 30, no. 4, pp. 1581–1586, 2013. View at Publisher · View at Google Scholar · View at Scopus
  60. M. L. Smith, J. M. Ford, M. C. Hollander et al., “p53-mediated DNA repair responses to UV radiation: studies of mouse cells lacking p53, p21, and/or gadd45 genes,” Molecular and Cellular Biology, vol. 20, no. 10, pp. 3705–3714, 2000. View at Publisher · View at Google Scholar · View at Scopus
  61. K. Somasundaram and W. S. El-Deiry, “Tumor suppressor p53: regulation and function,” Frontiers in Bioscience, vol. 5, pp. D424–D437, 2000. View at Google Scholar
  62. H. Watanabe, Z.-Q. Pan, N. Schreiber-Agus, R. A. DePinho, J. Hurwitz, and Y. Xiong, “Suppression of cell transformation by the cyclin-dependent kinase inhibitor p57KIP2 requires binding to proliferating cell nuclear antigen,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 4, pp. 1392–1397, 1998. View at Publisher · View at Google Scholar · View at Scopus
  63. N. Haga, N. Fujita, and T. Tsuruo, “Involvement of mitochondrial aggregation in arsenic trioxide (As2O3)-induced apoptosis in human glioblastoma cells,” Cancer Science, vol. 96, no. 11, pp. 825–833, 2005. View at Publisher · View at Google Scholar · View at Scopus
  64. A. I. Scovassi and G. G. Poirier, “Poly(ADP-ribosylation) and apoptosis,” Molecular and Cellular Biochemistry, vol. 199, no. 1-2, pp. 125–137, 1999. View at Publisher · View at Google Scholar · View at Scopus
  65. M. Goto, “Elevation of soluble Fas (APO-1, CD95) ligand in natural aging and Werner syndrome,” Aging, vol. 11, p. 13, 2008. View at Google Scholar
  66. H. Wajant, “The Fas signaling pathway: more than a paradigm,” Science, vol. 296, no. 5573, pp. 1635–1636, 2002. View at Publisher · View at Google Scholar · View at Scopus
  67. F. Qi, Y. Inagaki, B. Gao et al., “Bufalin and cinobufagin induce apoptosis of human hepatocellular carcinoma cells via Fas- and mitochondria-mediated pathways,” Cancer Science, vol. 102, no. 5, pp. 951–958, 2011. View at Publisher · View at Google Scholar · View at Scopus
  68. F. Qi, A. Li, Y. Inagaki et al., “Induction of apoptosis by cinobufacini preparation through mitochondria- and Fas-mediated caspase-dependent pathways in human hepatocellular carcinoma cells,” Food and Chemical Toxicology, vol. 50, no. 2, pp. 295–302, 2012. View at Publisher · View at Google Scholar · View at Scopus
  69. L.-W. Shao, L.-H. Huang, S. Yan, J.-D. Jin, and S.-Y. Ren, “Cordycepin induces apoptosis in human liver cancer HepG2 cells through extrinsic and intrinsic signaling pathways,” Oncology Letters, vol. 12, no. 2, pp. 995–1000, 2016. View at Publisher · View at Google Scholar · View at Scopus
  70. A. Venturi, F. D. Piaz, C. Giovannini, L. Gramantieri, P. Chieco, and L. Bolondi, “Human hepatocellular carcinoma expresses specific PCNA isoforms: an in vivo and in vitro evaluation,” Laboratory Investigation, vol. 88, no. 9, pp. 995–1007, 2008. View at Publisher · View at Google Scholar · View at Scopus
  71. E. Prosperi, “The fellowship of the rings: distinct pools of proliferating cell nuclear antigen trimer at work,” The FASEB Journal, vol. 20, no. 7, pp. 833–837, 2006. View at Publisher · View at Google Scholar · View at Scopus
  72. T. Paunesku, S. Mittal, M. Protić et al., “Proliferating cell nuclear antigen (PCNA): ringmaster of the genome,” International Journal of Radiation Biology, vol. 77, no. 10, pp. 1007–1021, 2001. View at Publisher · View at Google Scholar · View at Scopus
  73. T. Kiya, T. Endo, T. Goto et al., “Apoptosis and PCNA expression induced by prolactin in structural involution of the rat corpus luteum,” Journal of Endocrinological Investigation, vol. 21, no. 5, pp. 276–283, 1998. View at Publisher · View at Google Scholar · View at Scopus
  74. X. Liu, F. Ye, J. Wu, B. How, W. Li, and D. Y. Zhang, “Signaling proteins and pathways affected by flavonoids in leukemia cells,” Nutrition and Cancer, vol. 67, no. 2, pp. 238–249, 2015. View at Publisher · View at Google Scholar · View at Scopus
  75. V. Stepanić, A. Č. Gašparović, K. G. Trošelj, D. Amić, and N. Žarković, “Selected attributes of polyphenols in targeting oxidative stress in cancer,” Current Topics in Medicinal Chemistry, vol. 15, no. 5, pp. 496–509, 2015. View at Publisher · View at Google Scholar · View at Scopus
  76. R. H. Patil, R. L. Babu, M. Naveen Kumar et al., “Apigenin inhibits PMA-induced expression of pro-inflammatory cytokines and AP-1 factors in A549 cells,” Molecular and Cellular Biochemistry, vol. 403, no. 1-2, pp. 95–106, 2015. View at Publisher · View at Google Scholar · View at Scopus
  77. K.-C. Li, Y.-L. Ho, W.-T. Hsieh, S.-S. Huang, Y.-S. Chang, and G.-J. Huang, “Apigenin-7-glycoside prevents LPS-induced acute lung injury via downregulation of oxidative enzyme expression and protein activation through inhibition of MAPK phosphorylation,” International Journal of Molecular Sciences, vol. 16, no. 1, pp. 1736–1754, 2015. View at Publisher · View at Google Scholar · View at Scopus
  78. D. Arango, M. Diosa-Toro, L. S. Rojas-Hernandez et al., “Dietary apigenin reduces LPS-induced expression of miR-155 restoring immune balance during inflammation,” Molecular Nutrition and Food Research, vol. 59, no. 4, pp. 763–772, 2015. View at Publisher · View at Google Scholar · View at Scopus
  79. S. Shukla and S. Gupta, “Apigenin: a promising molecule for cancer prevention,” Pharmaceutical Research, vol. 27, no. 6, pp. 962–978, 2010. View at Publisher · View at Google Scholar · View at Scopus
  80. X. Ma, Y.-F. Li, Q. Gao et al., “Inhibition of superoxide anion-mediated impairment of endothelium by treatment with luteolin and apigenin in rat mesenteric artery,” Life Sciences, vol. 83, no. 3-4, pp. 110–117, 2008. View at Publisher · View at Google Scholar · View at Scopus
  81. Y.-J. Jeong, Y.-J. Choi, J.-S. Choi et al., “Attenuation of monocyte adhesion and oxidised LDL uptake in luteolin-treated human endothelial cells exposed to oxidised LDL,” British Journal of Nutrition, vol. 97, no. 3, pp. 447–457, 2007. View at Publisher · View at Google Scholar · View at Scopus
  82. O. Popa, N. E. Băbeanu, I. Popa, S. Niță, and C. E. Dinu-Pârvu, “Methods for obtaining and determination of squalene from natural sources,” BioMed Research International, vol. 2015, Article ID 367202, 16 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  83. J. D. Kedl and R. M. Kedl, “How squalene GLAdly helps generate antigen-specific T cells via antigen-carrying neutrophils and IL-18,” European Journal of Immunology, vol. 45, no. 2, pp. 376–379, 2015. View at Publisher · View at Google Scholar · View at Scopus
  84. Z. Chen, S. Kong, F. Song, L. Li, and H. Jiang, “Pharmacokinetic study of luteolin, apigenin, chrysoeriol and diosmetin after oral administration of Flos Chrysanthemi extract in rats,” Fitoterapia, vol. 83, no. 8, pp. 1616–1622, 2012. View at Publisher · View at Google Scholar · View at Scopus
  85. W. Dewé, C. Durand, S. Marion, L. Oostvogels, J. Devaster, and M. Fourneau, “A multi-criteria decision making approach to identify a vaccine formulation,” Journal of Biopharmaceutical Statistics, vol. 26, no. 2, pp. 352–364, 2015. View at Publisher · View at Google Scholar
  86. M. A. Tegenge and R. J. Mitkus, “A first-generation physiologically based pharmacokinetic (PBPK) model of alpha-tocopherol in human influenza vaccine adjuvant,” Regulatory Toxicology and Pharmacology, vol. 71, no. 3, pp. 353–364, 2015. View at Publisher · View at Google Scholar · View at Scopus
  87. B. P. Ezhilan and R. Neelamegam, “GC-MS analysis of phytocomponents in the ethanol extract of Polygonum chinense L.,” Pharmacognosy Research, vol. 4, no. 1, pp. 11–14, 2012. View at Publisher · View at Google Scholar · View at Scopus
  88. G. S. Kelly, “Squalene and its potential clinical uses,” Alternative Medicine Review, vol. 4, no. 1, pp. 29–36, 1999. View at Google Scholar · View at Scopus
  89. G. Pandino, S. Lombardo, A. Moglia, E. Portis, S. Lanteri, and G. Mauromicale, “Leaf polyphenol profile and SSR-based fingerprinting of new segregant Cynara cardunculus genotypes,” Frontiers in Plant Science, vol. 5, article 800, 2015. View at Publisher · View at Google Scholar · View at Scopus
  90. A. A. Alshatwi, G. Shafi, T. N. Hasan, N. A. Syed, and K. K. Khoja, “Fenugreek induced apoptosis in breast cancer MCF-7 cells mediated independently by fas receptor change,” Asian Pacific Journal of Cancer Prevention, vol. 14, no. 10, pp. 5783–5788, 2013. View at Publisher · View at Google Scholar · View at Scopus
  91. S. Shabbeer, M. Sobolewski, R. K. Anchoori et al., “Fenugreek: a naturally occurring edible spice as an anticancer agent,” Cancer Biology and Therapy, vol. 8, no. 3, pp. 272–278, 2009. View at Publisher · View at Google Scholar · View at Scopus